Adrenomedullin vs Vasostatin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Adrenomedullin (ADM) is a 52-amino acid vasoactive peptide first isolated from human pheochromocytoma tissue in 1993. It is now recognized as a pleiotropic hormone produced widely throughout the body, with highest expression in the adrenal medulla, heart, lung, kidney, and vascul...
Calculate Adrenomedullin dose →Vasostatin refers to the N-terminal fragments of chromogranin A (CgA), particularly CgA1-76 (Vasostatin-1) and CgA1-113 (Vasostatin-2), generated by proteolytic processing of the chromogranin A precursor. While catestatin (CgA352-372) is the C-terminal CgA fragment with anti-cate...
Calculate Vasostatin dose →| Parameter | Adrenomedullin | Vasostatin |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Clinical | Preclinical Research |
| Half-Life | 22 min (plasma) | ~20-30 minutes (estimated) |
| Typical Dose | 2-10 ng/kg/min (IV infusion) | 0.1-10 nmol/kg IV (animal) |
| Frequency | Acute infusion or short course | Acute dosing |
| Route | Intravenous, Subcutaneous | IV (research) |
| FDA Status | Not approved | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.